Portfolio Company · Operating Co.

Immune-Onc Therapeutics

Sector not classified · Website

Immune-Onc Therapeuticsbacked byVivo Capital

Current

Company Snapshot

Immune-Onc Therapeutics is a portfolio company held by Vivo Capital. Profile compiled from public sources; submit updates to extend the public record.

Sector—

Parent PE firmVivo Capital

Ownership statusCurrent

WebsiteVisit ↗

Ownership Context

Immune-Onc Therapeutics is a current portfolio company of Vivo Capital. Public coverage of this company is grouped under its parent firm's profile.

Sources

https://vivocapital.com/portfolio

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Immune-Onc Therapeutics and does not provide investment advice.

Other portfolio companies of Vivo Capital

Aadi Bioscience

Ablaze Pharmaceuticals

Achieve Life Sciences

Ajax Therapeutics Inc.

See the full Vivo Capital portfolio.